Statistics

Total Visits

Views
A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results70

Select a period of time:

Number of views in the range

Views
A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results40

Views

Views
February 20253
March 202512
April 20254
May 20252
June 20253
July 202513
August 20253
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States17
Singapore11
Brazil4
Argentina1
Barbados1
Canada1
Spain1
Ethiopia1
France1
United Kingdom1
 

Top cities views

Views
Addis Ababa1
Ankara1
Atlanta1
Belo Horizonte1
Brooklyn1
Buffalo1
Cagnes-sur-Mer1
Carteret1
Caxias do Sul1
Concord1